TNF-α Decreases VEGF Secretion in Highly Polarized RPE Cells but Increases It in Non-Polarized RPE Cells Related to Crosstalk between JNK and NF-κB Pathways

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Terasaki, Hiroto ^a   Kase, Satoru ^b   Shirasawa, Makoto ^a   Otsuka, Hiroki ^a   Hisatomi, Toshio ^c   Sonoda, Shozo ^a   Ishida, Susumu ^b   Ishibashi, Tatsuro ^c   Sakamoto, Taiji ^a  

^a KAGOSHIMA UNIVERSITY   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

^c KYUSHU UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; STRESS ACTIVATED PROTEIN KINASE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ATROPHY; CELL POLARITY; CELL STRUCTURE; CHOROID; CHOROID ATROPHY; CONTROLLED STUDY; DOWN REGULATION; INFLAMMATION; NICK END LABELING; NONHUMAN; PIGMENT EPITHELIUM; PROTEIN SECRETION; RAT; SWINE; UPREGULATION;

ANIMALS; CELL POLARITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; MAP KINASE SIGNALING SYSTEM; MICROSCOPY, ELECTRON, TRANSMISSION; NF-KAPPA B; RATS; RETINAL PIGMENT EPITHELIUM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SWINE; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84880828301     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0069994     Document Type: Article

References (42)

1. Anderson JM, Van Itallie CM, (1995) Tight junctions and the molecular basis for regulation of paracellular permeability. Am J Physiol 269: G467-475.
2. Marmor MF, Abdul-Rahim AS, Cohen DS, (1980) The effect of metabolic inhibitors on retinal adhesion and subretinal fluid resorption. Invest Ophthalmol Vis Sci 19: 893-903.
3. Miller SS, Hughes BA, Machen TE, (1982) Fluid transport across retinal pigment epithelium is inhibited by cyclic AMP. Proc Natl Acad Sci U S A 79: 2111-2115.
4. Rizzolo LJ, (1997) Polarity and the development of the outer blood-retinal barrier. Histol Histopathol 12: 1057-1067.
5. Rodriguez-Boulan E, Nelson WJ, (1989) Morphogenesis of the polarized epithelial cell phenotype. Science 245: 718-725.
6. Blaauwgeers HG, Holtkamp GM, Rutten H, Witmer AN, Koolwijk P, et al. (1999) Polarized vascular endothelial growth factor secretion by human retinal pigment epithelium and localization of vascular endothelial growth factor receptors on the inner choriocapillaris. Evidence for a trophic paracrine relation. Am J Pathol 155: 421-428.
7. Marneros AG, Fan J, Yokoyama Y, Gerber HP, Ferrara N, et al. (2005) Vascular endothelial growth factor expression in the retinal pigment epithelium is essential for choriocapillaris development and visual function. Am J Pathol 167: 1451-1459.
8. Saint-Geniez M, Kurihara T, Sekiyama E, Maldonado AE, D'Amore PA, (2009) An essential role for RPE-derived soluble VEGF in the maintenance of the choriocapillaris. P Natl Acad Sci USA 106: 18751-18756.
9. Baffert F, Le T, Sennino B, Thurston G, Kuo CJ, et al. (2006) Cellular changes in normal blood capillaries undergoing regression after inhibition of VEGF signaling. Am J Physiol Heart Circ Physiol 290: H547-559.
10. Storkebaum E, Lambrechts D, Carmeliet P, (2004) VEGF: once regarded as a specific angiogenic factor, now implicated in neuroprotection. Bioessays 26: 943-954.
11. Nishijima K, Ng YS, Zhong L, Bradley J, Schubert W, et al. (2007) Vascular endothelial growth factor-A is a survival factor for retinal neurons and a critical neuroprotectant during the adaptive response to ischemic injury. Am J Pathol 171: 53-67.
12. Friedman DS, O'Colmain BJ, Munoz B, Tomany SC, McCarty C, et al. (2004) Prevalence of age-related macular degeneration in the United States. Arch Ophthalmol 122: 564-572.
13. Frank RN, Amin RH, Eliott D, Puklin JE, Abrams GW, (1996) Basic fibroblast growth factor and vascular endothelial growth factor are present in epiretinal and choroidal neovascular membranes. Am J Ophthalmol 122: 393-403.
14. Lopez PF, Sippy BD, Lambert HM, Thach AB, Hinton DR, (1996) Transdifferentiated retinal pigment epithelial cells are immunoreactive for vascular endothelial growth factor in surgically excised age-related macular degeneration-related choroidal neovascular membranes. Invest Ophthalmol Vis Sci 37: 855-868.
15. Oh H, Takagi H, Takagi C, Suzuma K, Otani A, et al. (1999) The potential angiogenic role of macrophages in the formation of choroidal neovascular membranes. Invest Ophthalmol Vis Sci 40: 1891-1898.
16. Bian ZM, Elner SG, Elner VM, (2007) Regulation of VEGF mRNA expression and protein secretion by TGF-beta2 in human retinal pigment epithelial cells. Exp Eye Res 84: 812-822.
17. Nagineni CN, Kommineni VK, William A, Detrick B, Hooks JJ, (2012) Regulation of VEGF expression in human retinal cells by cytokines: implications for the role of inflammation in age-related macular degeneration. J Cell Physiol 227: 116-126.
18. Hollyfield JG, Bonilha VL, Rayborn ME, Yang X, Shadrach KG, et al. (2008) Oxidative damage-induced inflammation initiates age-related macular degeneration. Nat Med 14: 194-198.
19. Zarbin MA, (2004) Current concepts in the pathogenesis of age-related macular degeneration. Arch Ophthalmol 122: 598-614.
20. Josko J, Mazurek M, (2004) Transcription factors having impact on vascular endothelial growth factor (VEGF) gene expression in angiogenesis. Med Sci Monit 10: RA89-98.
21. Klettner A, Roider J, (2009) Constitutive and oxidative-stress-induced expression of VEGF in the RPE are differently regulated by different Mitogen-activated protein kinases. Graefes Arch Clin Exp Ophthalmol 247: 1487-1492.
22. Bok D (1993) The retinal pigment epithelium: a versatile partner in vision. J Cell Sci Suppl 17: 189-195.
23. Burke JM, (2008) Epithelial phenotype and the RPE: is the answer blowing in the Wnt? Prog Retin Eye Res 27: 579-595.
24. Sonoda S, Spee C, Barron E, Ryan SJ, Kannan R, et al. (2009) A protocol for the culture and differentiation of highly polarized human retinal pigment epithelial cells. Nat Protoc 4: 662-673.
25. Sonoda S, Sreekumar PG, Kase S, Spee C, Ryan SJ, et al. (2010) Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration. Aging (Albany NY) 2: 28-42.
26. Killingsworth MC, Sarks JP, Sarks SH, (1990) Macrophages Related to Bruchs Membrane in Age-Related Macular Degeneration. Eye 4: 613-621.
27. Shi X, Semkova I, Muther PS, Dell S, Kociok N, et al. (2006) Inhibition of TNF-alpha reduces laser-induced choroidal neovascularization. Exp Eye Res 83: 1325-1334.
28. Woo JM, Shin DY, Lee SJ, Joe Y, Zheng M, et al. (2012) Curcumin protects retinal pigment epithelial cells against oxidative stress via induction of heme oxygenase-1 expression and reduction of reactive oxygen. Mol Vis 18: 901-908.
29. Bian ZM, Elner SG, Elner VM, (2007) Thrombin-induced VEGF expression in human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci 48: 2738-2746.
30. Martelli A, Bernabo N, Berardinelli P, Russo V, Rinaldi C, et al. (2009) Vascular supply as a discriminating factor for pig preantral follicle selection. Reproduction 137: 45-58.
31. Otsuka H, Arimura N, Sonoda S, Nakamura M, Hashiguchi T, et al. (2010) Stromal cell-derived factor-1 is essential for photoreceptor cell protection in retinal detachment. Am J Pathol 177: 2268-2277.
32. Yoshinaga N, Arimura N, Otsuka H, Kawahara K, Hashiguchi T, et al. (2011) NSAIDs inhibit neovascularization of choroid through HO-1-dependent pathway. Lab Invest 91: 1277-1290.
33. Takahashi E, Nagano O, Ishimoto T, Yae T, Suzuki Y, et al. (2010) Tumor necrosis factor-alpha regulates transforming growth factor-beta-dependent epithelial-mesenchymal transition by promoting hyaluronan-CD44-moesin interaction. J Biol Chem 285: 4060-4073.
34. Yin Y, Wang S, Sun Y, Matt Y, Colburn NH, et al. (2009) JNK/AP-1 pathway is involved in tumor necrosis factor-alpha induced expression of vascular endothelial growth factor in MCF7 cells. Biomed Pharmacother 63: 429-435.
35. De Smaele E, Zazzeroni F, Papa S, Nguyen DU, Jin RG, et al. (2001) Induction of gadd45 beta by NF-kappa B downregulates pro-apoptotic JNK signalling. Nature 414: 308-313.
36. Papa S, Bubici C, Zazzeroni F, Franzoso G, (2009) Mechanisms of liver disease: cross-talk between the NF-kappaB and JNK pathways. Biol Chem 390: 965-976.
37. Tang G, Minemoto Y, Dibling B, Purcell NH, Li Z, et al. (2001) Inhibition of JNK activation through NF-kappaB target genes. Nature 414: 313-317.
38. Karin M, (2006) Nuclear factor-kappaB in cancer development and progression. Nature 441: 431-436.
39. Guma M, Rius J, Duong-Polk KX, Haddad GG, Lindsey JD, et al. (2009) Genetic and pharmacological inhibition of JNK ameliorates hypoxia-induced retinopathy through interference with VEGF expression. Proc Natl Acad Sci U S A 106: 8760-8765.
40. Pages G, Berra E, Milanini J, Levy AP, Pouyssegur J, (2000) Stress-activated protein kinases (JNK and p38/HOG) are essential for vascular endothelial growth factor mRNA stability. Journal of Biological Chemistry 275: 26484-26491.
41. Yoshino Y, Aoyagi M, Tamaki M, Duan L, Morimoto T, et al. (2006) Activation of p38 MAPK and/or JNK contributes to increased levels of VEGF secretion in human malignant glioma cells. Int J Oncol 29: 981-987.
42. Honorati MC, Cattini L, Facchini A, (2004) IL-17, IL-1beta and TNF-alpha stimulate VEGF production by dedifferentiated chondrocytes. Osteoarthritis Cartilage 12: 683-691.